Zacks Sell List Highlights: Revlon, VCA Antech, Meridian Bioscience and Stillwater Mining Company - Press Releases

For Immediate Release

Chicago, IL –September 16, 2010 – Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List – Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): Revlon, Inc. (REV) and VCA Antech, Inc. (WOOF). Further, Zacks announced #4 Rankings (Sell) on two other widely held stocks: Meridian Bioscience, Inc. (VIVO) and Stillwater Mining Company (SWC). To see the full Zacks #5 Rank List - Stocks to Sell Now visit: http://at.zacks.com/?id=5522

Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List of Stocks to Sell Now by 80% annually (+2% vs. +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid.

Here is a synopsis of why REV and WOOF have a Zacks Rank of #5 (Strong Sell) and should most likely be sold or avoided for the next one to three months. Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the Zacks Rank universe:

Revlon, Inc. (REV) announced second-quarter earnings of 31 cents per share on July 29 that missed analysts' expectations by more than18%. The Zacks Consensus Estimate for the current year slipped 11 cents to $ 1.50 per share in the last 60 days Next year's estimate dipped by the same amount to $1.70 per share in that time span.

VCA Antech, Inc. (WOOF) posted a second-quarter earnings of 44 cents per share on July 22, which came in 5 cents below the average forecast. The Zacks Consensus Estimate for the full year fell to a profit of 16 cents per share from $1.47 over the past two months. For 2011 analysts expects the estimates to fall to $1.60, which would be a decrease of 20 cents in the same time period.

Here is a synopsis of why VIVO and SWC have a Zacks Rank of 4 (Sell) and should also most likely be sold or avoided for the next one to three months. Note that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks;

Meridian Bioscience, Inc. (VIVO) third-quarter earnings of 17 cents per share, posted on July 20, lagged analysts' projections by 5.6%. For 2010, the Zacks Consensus Estimate moved down 6 cents to 70 cents per share in the last two months as 5 out of 8 covering analysts cut back on forecasts. Estimate for next year slid 10 cents to 81 cents per share during that time period.

Stillwater Mining Company (SWC)reported a second-quarter profit of 15 cents per share on July 28 that fell 35% short of the Zacks Consensus Estimate. The full-year average forecast is currently 57 cents per share, compared with a profit of 95 cents projected two months ago. During that time, the only covering analyst revised downward. Next year's forecast dropped 50 cents to $1.17 per share in the same period.

Truly taking advantage of the Zacks Rank requires the understanding of how it works. The free special report; “Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions” is available to provide this insightful background. Download a free copy now to prosper in the years to come at http://at.zacks.com/?id=5523

Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." Since inception in 1988, #1 Rank Stocks have generated an average annual return of +28%. During the 2000-2002 bear market, Zacks #1 Rank stocks gained +43.8%, while the S&P 500 tumbled -37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have significantly underperformed the S&P 500 (+2% versus +10%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks “Profit from the Pros” e-mail newsletter offers continuous coverage of Zacks Rank Buy stocks and highlights those stocks poised to outperform the market. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=5526

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5527

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact: Michael Vodicka
Company: Zacks.com
Phone: 312-265-9226
Email: pr@zacks.com
Visit: www.zacks.com

 

 
REVLON INC-A (REV): Free Stock Analysis Report
 
STILLWATER MNG (SWC): Free Stock Analysis Report
 
MERIDIAN BIOSCI (VIVO): Free Stock Analysis Report
 
VCA ANTECH INC (WOOF): Free Stock Analysis Report
 
Zacks Investment Research